Labyrinth One

Revolutionizing CTC Enrichment System

Meet us at AACR 2025

Developed by Dr. Sunitha Nagrath,
Pioneer in Liquid Biopsy

Labyrinth technology was originally developed by Prof. Sunitha Nagrath and her team at the University of Michigan. With decades of expertise in liquid biopsy, they designed the most advanced, reliable, and cost-effective system for circulating tumor cell (CTC) enrichment. Labyrinth One brings this cutting-edge technology into real-world applications, providing researchers and clinicians with a powerful tool for cancer diagnostics and precision medicine.

Nagrath Lab

Labyrinth One: Automated CTC Enrichment System

Labyrinth One is the next-generation circulating tumor cell (CTC) enrichment system, engineered to bring unparalleled precision and efficiency to liquid biopsy workflows. By leveraging advanced microfluidic technology, Labyrinth One isolates CTCs with high purity, without the need for labels or invasive processing. Designed for both research and clinical applications, it seamlessly integrates into existing workflows, offering a powerful tool for cancer detection, monitoring, and personalized treatment strategies. With its automated operation, high throughput, and exceptional viability of captured cells, Labyrinth One is setting a new standard in non-invasive cancer diagnostics.

Precision and Purity

Achieves highly selective CTC enrichment without labels.

Viable Cell Recovery

Preserves live cells for downstream molecular analysis.

High Throughput

Processes RBC depleted blood samples in minutes.

Plug-and-Play System

Fully automated, easy-to-use design.